Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Dr. Emmanuel Barillot Receives Agilent Thought Leader Award

Published: Friday, August 30, 2013
Last Updated: Friday, August 30, 2013
Bookmark and Share
Award will support Dr. Barillot’s Web-based tools for cancer and drug-safety research.

Agilent Technologies Inc. has announced that Dr. Emmanuel Barillot, director of Bioinformatics and Systems IT at the Institut Curie in Paris, has received an Agilent Thought Leader Award in recognition of his pioneering development of user-friendly, Web-based bioinformatics tools for systems toxicology.

The award will support Dr. Barillot’s work in developing a database of cellular signaling pathways and a visualization tool to help the pharmaceutical industry develop more effective cancer treatments.

The new Web-based visualization tool will augment the institute’s Atlas of Cancer Signaling Networks and will be further enhanced by the combined capabilities of Curie’s NaviCell mapping tool and Agilent’s GeneSpring software and NMR technologies.

Together, these tools will enable researchers to identify off-pathway effects that could lead to undesirable outcomes, such as DNA damage.

“Assessing the safety and potential toxicity of drug candidates is a significant hurdle in the extraordinarily complex, labor-intensive drug development process,” said Tony Owen, Agilent’s senior director of life science marketing and market development.

Owen continued, “Pharmaceutical companies can spend many years and billions of dollars only to find that a once-promising preclinical therapeutic compound is actually harmful to patients in clinical tests. It is incumbent upon drug developers to find ways to assess drug toxicity much earlier in the process to reduce R&D time, minimize costs and maximize patient benefits.”

“The Agilent Thought Leader Award will accelerate the further development of the Curie Atlas of Cancer Signaling Networks, a comprehensive and freely available cancer pathway database, and NaviCell network visualization tool,” said Dr. Barillot. “These tools will enable earlier identification and visualization of toxic interactions between signaling pathways during the discovery and development of therapeutics for the treatment of cancer, thus enabling better informed drug-candidate selection and prioritization. They will also be useful for interpreting high-throughput biological data, like next-generation sequencing profiles of tumors or other samples.”

The Agilent Thought Leader Award promotes fundamental scientific advances by contributing financial support, products and expertise to the research of influential thought leaders in the life sciences and chemical analysis space.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent Technologies Launches New Products for Analyzing Biotherapeutics
Expanded AdvanceBio portfolio enables scientists to speed research and lower costs.
Thursday, June 25, 2015
Agilent’s Thought Leader Award Supports Dr. Paul Watkins
Dr. Watkins has received the award in recognition of his ongoing work developing integrated methods to predict DILI.
Thursday, January 23, 2014
Agilent Technologies to Separate into Two Public Companies
Life sciences, diagnostics and applied markets (LDA) that will retain the Agilent name, and the other company will be comprised of Agilent's electronic measurement (EM) products.
Monday, September 23, 2013
Agilent to Sponsor Global Forensics Congress in Portugal
Latest LC, GC, MS and mobile-measurement solutions to be featured at September event.
Tuesday, August 27, 2013
Agilent Technologies and Ameritox Form Collaboration
Agilent Technologies Inc. and AmeritoxSM announced that they have formed a research collaboration that could accelerate analysis in the field of medication monitoring.
Tuesday, February 12, 2013
Agilent Supports Russell Thomas’ Research at the Hamner Institutes for Health Sciences
Russell supported for his work developing methods to predict drug-induced liver injury.
Thursday, December 08, 2011
Agilent Technologies’ LC/MS Manufacturing Achieves ISO 13485 Certification
6100 Series single quadrupole and 6400 Series triple quadrupole systems now manufactured under ISO 13485 certification.
Monday, September 12, 2011
Agilent Technologies Collaborates with UC Davis on Breakthrough Food-Safety Research
Technology aims to revolutionize food safety by reducing identification time of food-borne bacteria.
Thursday, December 09, 2010
Agilent and Johns Hopkins to Research Toxicity Pathways for Embryonic Brain Development Using Metabolomics
The work could help identify possible contributions of chemicals to disorders such as autism and attention hyperactivity disorders.
Friday, August 20, 2010
BIOCIUS and Agilent Launch High-throughput, RapidFire® Mass Solution for Drug Discovery
Advanced, integrated system for high quality in vitro ADME analysis unveiled at ASMS Conference, May 23-May 27.
Friday, May 21, 2010
Automatic Productivity for Life Science Discovery
Agilent Automation Solutions has announced a 12-page brochure 'Automatic productivity for life science discovery.'
Friday, March 26, 2010
Agilent and the National Center for Food Safety and Technology Collaborate to Develop Food Testing Methods
The collaboration will develop new scientific methods for food testing to solve problems facing global food supply chains.
Wednesday, March 03, 2010
Phytronix and Agilent to Co-Market Phytronix LDTD Ion Source with Agilent Mass Spectrometers
The non-exclusive co-marketing agreement aims to promote the Phytronix Laser Diode Thermal Desorption Ion Source with Agilent mass spectrometers.
Wednesday, June 10, 2009
Regulators OK Agilent buy of Stratagene
Federal Antitrust Regulators Approve Agilent's Purchase of Stratagene
Monday, May 14, 2007
FDA Selects Agilent’s Dual-Mode Platform for MAQC Project
FDA will use Agilent’s dual-mode platform for pharmacogenomics and toxicogenomics studies.
Friday, January 13, 2006
Scientific News
Development in Preventing Macular Degeneration
Following macular degeneration insight, promising drugs to prevent vision loss have been identified.
Improving Tumour Therapy with Nanoparticles
UHN nanoparticle called PEARLs is a promising utilisation of photo-thermal therapy for cancer treatment.
New Antidepressant Treatment Discovered
Scientists have demonstrated how gene therapy could lead to new treatments for depression.
Cellular Origin of Skin Cancer Identified
Scientists have identified ‘cell of origin’ in the most common form of skin cancer, and followed the process that leads to tumour growth.
Enhancing Drug Safety with a Web-Based Data Tool
Online and open-access tool allows anyone to find, combine and analyse FDA drug information.
Genetic Missing Link Could Explain Mystery of Heritability
Mother’s diet during pregnancy can permanently affect offspring attributes through process that could be strongly influenced by genetic variation in an unexpected part of the genome.
Does the Transport of Next-Gen Vaccines Lie with E.coli?
Study shows harmless E.coli capsule could aid next-gen vaccine delivery and efficiency.
Breathing in a Cure
Researchers working on inhalable ibuprofen to treat cystic fibrosis.
Complex Mouse Behaviours Linked to the Genes that Influence Them
Two novel genes were associated with methamphetamine sensitivity and anxiety-like behavior.
One Giant Leap for the Future of Safe Drug Delivery
Sheffield engineers make major breakthrough in developing silk ‘micro-rockets’ that can be used safely in biological environments.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!